All News

A pharmacist looks back at what he was told in pharmacy school.

Daily and monthly aspects of pharmacy accounting and tax preparation and planning can be complex and difficult. Proper pharmacy accounting comes down to making sure your books are current, have integrity, and operate efficiently.

A look at the ways coaching your patients can leave them healthier.

The biggest innovation in medicine in the last decade (and how to get in on it).

BPS has been adding more board certifications-but they're not done yet.

Using a system that automatically contacts patients with prescription reminders and other information can boost loyalty and star ratings.

A New Mexico pharmacist's actions brought an ACLU lawsuit.

A drug underdevelopment may provide another pathway to lowering LDL levels.

Clinical rotation gives students unique view of medical cannabis industry.

New study indicates emergency contraception is not available to all who might need it.

A new study looks at how pharmacists can prevent medication-related admissions.

Revised ISMP tool helps pharmacies see where they may be missing best practices.

From a 1970s column, “silly syndrome,” the best customer stories of the decade.

The agency is trying to deliver on its goal of a 90-day response time.

A new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.

A collaboration between the pharmacy and LabCorp will provide specimen collection services.

After anti-trust woes, the acquisition is thrown out and Walgreens buys over 2,000 stores.

The owner of Indiana-based Pharmakon Pharmaceuticals is charged with distributing adulterated drugs and lying to the FDA.

The NECC tragedy comes to a close as Barry Cadden is sentenced.

Why some red yeast rice supplements could be considered prescription drugs.

Easy-to-swallow bits of news from around the world of pharmacy.

Two groups join up to help the Massachusetts State Office of Pharmacy Services.

Younger people, females, black or Hispanic less likely to have medication.

Report looks at possible impediments to growth in the specialty market, including patient access.

High court ruling should make biosimilars available faster.